000			01683nam a22002297a 4500
005			20250212160903.0
008			190329b2014 xxu||||| |||| 00| 0 eng d
020			_a9783527329373
082			_a615.37 DUB-S
100			_aedited by Dubel, Stefan
245			_aHandbook of therapeutic antibodies : _bapproved therapeutic antibodies : Volume 3 / _cedited by Stefan Dubel and Janice M. Reichert
250			_a2nd ed.
260			_aGermany _bWiley Blackwell _c2014
300			_a1289-1732 p.
365			_aUSD _b999.95. (Set of 4 Volumes).
440			_vVolume - 3. _aApproved therapeutic antibodies.
500			_aStill the most comprehensive reference source on the development, production and therapeutic application of antibodies, this second edition is thoroughly updated and now has 30% more content. Volume 1 covers selection and engineering strategies for new antibodies, while the second volume presents novel therapeutic concepts and antibodies in clinical study, as well as their potential. Volumes 3 and 4 feature detailed and specific information about each antibody approved for therapeutic purposes, including clinical data. This unique handbook concludes with a compendium of marketed monoclonal antibodies and an extensive index. Beyond providing current knowledge, the authors discuss emerging technologies, future developments, and intellectual property issues, such that this handbook meets the needs of academic researchers, decision makers in industry and healthcare professionals in the clinic.
650			_aImmunoglobulins--Biotechnology
650			_aImmunoglobulins--Therapeutic use
650			_aImmunopharmacology
700			_aReichert, Janice M.
999			_c66264 _d66264